Pharmacokinetics of cefepime in subjects with renal insufficiency

[1]  G. Matzke,et al.  Disposition of the cephalosporin cefepime in normal and renally impaired subjects. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[2]  D. Weidler,et al.  Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses , 1990, Antimicrobial Agents and Chemotherapy.

[3]  S. Forgue,et al.  N-oxidation of N-methylpyrrolidine released in vivo from cefepime. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[4]  K. Pittman,et al.  High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine , 1987, Antimicrobial Agents and Chemotherapy.

[5]  K. Kim,et al.  Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci , 1985, Antimicrobial Agents and Chemotherapy.

[6]  R. Auckenthaler,et al.  Clinical Pharmacokinetics of the Third Generation Cephalosporins , 1985, Clinical pharmacokinetics.

[7]  M. Sande,et al.  New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits , 1985, Antimicrobial Agents and Chemotherapy.

[8]  K. E. Price,et al.  Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics , 1985, Antimicrobial Agents and Chemotherapy.

[9]  J. Fillastre,et al.  Pharmacokinetics of ceftazidime in normal and uremic subjects , 1984, Antimicrobial Agents and Chemotherapy.

[10]  T. Marbury,et al.  Drug Therapy in Patients Undergoing Haemodialysis Clinical Pharmacokinetic Considerations , 1984, Clinical pharmacokinetics.

[11]  H. Lode,et al.  Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora , 1983, Antimicrobial Agents and Chemotherapy.

[12]  L. Sennello,et al.  Cefsulodin kinetics in renal impairment , 1982, Clinical pharmacology and therapeutics.

[13]  C. Lee.  The assessment of fractional drug removal by extracorporeal dialysis. , 1982, Biopharmaceutics & drug disposition.

[14]  H. Simmen,et al.  Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime. , 1982, Antimicrobial agents and chemotherapy.

[15]  L. Benet,et al.  Noncompartmental determination of the steady-state volume of distribution. , 1979, Journal of pharmaceutical sciences.

[16]  T. Marbury,et al.  Hemodialysis of Theophylline in Uremic Patients , 1979, Journal of clinical pharmacology.

[17]  花野 学.  序--Pharmacokinetics (Pharmacokinetics--薬物投与法の基礎と臨床 ) , 1978 .

[18]  J. Hull,et al.  The Effect of Disease States on Drug Pharmacokinetics , 1977 .

[19]  G. Levy,et al.  Hemodialysis clearance of theophylline. , 1977, JAMA.

[20]  L. Dettli.  Drug Dosage in Renal Disease , 1976, Clinical pharmacokinetics.